Abstract
Background
The risk of unprovoked seizures in patients with Alzheimer's disease (AD) is three-fold higher than the general population. However, no studies to date have reported on amyloid-β (Aβ) deposition in patients with Alzheimer's disease with epilepsy (ADEP).
Objective
The aim of this study was to collect clinical and positron emission tomography (PET)/magnetic resonance imaging (MRI) data from ADEP patients to compare and present the clinical characteristics and Aβ deposition patterns in this patient population.
Methods
Fifteen patients with ADEP, thirty-five patients with AD, twenty-three with late-onset epilepsy (LOEP), and twelve healthy controls were recruited. PET/MRI detected intracranial Aβ deposition, and differences in the brain regions distribution were compared between groups at the region of interest and voxel levels. Demographic data and medical history were further collected, while clinical and cognitive assessments were performed.
Results
In ADEP patients, the first seizure occurred in the early stages of AD, with focal-onset motor seizures accompanied by impaired consciousness being the predominant seizure type. Diagnosis and initiation of antiseizure medication (ASMs) were significantly delayed compared to LOEP patients. Additionally, the ADEP group showed less Aβ deposition in the middle cingulate gyrus than the AD group and had higher Mini-Mental State Exam and Montreal Cognitive Assessment scores.
Conclusions
This study reveals the clinical features and brain imaging differences between AD patients with and without EP, preliminarily confirming that the spatial deposition pattern of Aβ may be related to epilepsy and ASMs.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
